In BRCA1 gene-deficient ovarian cancer, PARPi upregulates PD-L1 expression by promoting the phosphorylation of CHK1 (a cell cycle checkpoint kinase), which is associated with reduced infiltration of CTL. Here, CD274 is linked to ovarian cancer.